Koninklijke DSM N.V.
KDSKF
Other OTC25.30
USD
-49.70
- -
CIK
0001339422
ISIN
NL0000009827
Return %
Stock
S&P500
1Y
-36.91
19.25
3Y
-88.58
65.11
5Y
-80.36
72.21
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Dimitri de Vreeze
- Full Time Employees
- 19,263
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- Het Overloon 1 Heerlen Netherlands 6411 TE
- IPO Date
- Jan 17, 2012
- CIK
- 0001339422
- Website
- dsm.com
- Similar Companies
- Business
- Koninklijke DSM N.V. (KDSKF) is a global science-based company focused on nutrition, health, and sustainable living, operating primarily in the segments of nutrition and health, animal nutrition, and materials sciences. The company develops and manufactures nutritional ingredients, medical nutrition products, early-life nutrition solutions, vitamins, enzymes, and probiotics for human and animal health; performance materials including engineering plastics, polyamides, and coatings; and sustainable biobased products such as fermented ingredients and renewable chemicals. Its offerings target consumer markets, healthcare professionals, food and beverage manufacturers, animal feed producers, and industrial clients across food, feed, pharma, and personal care industries. Headquartered in Heerlen, Netherlands, and founded in 1902 as a Dutch State Mine before evolving into a diversified nutrition and materials leader, DSM maintains extensive global operations with production facilities, R&D centers, and sales offices in over 50 countries, including major presence in Europe, North America, Asia-Pacific, and Latin America. Subsidiaries and joint ventures, such as DSM Nutritional Products and Fresenius Kabi (partnered for medical nutrition), support its integrated supply chain from innovation to commercialization. In recent developments, DSM completed its strategic separation from legacy businesses, fully demerging its engineering materials division into a standalone entity, Symphony Environmental Ltd., in 2023 to sharpen focus on nutrition and health growth areas. The company secured a major multi-year partnership with Mars, Incorporated in 2024 to co-develop sustainable pet nutrition solutions using precision fermentation technology. Additionally, DSM launched its YEASTIA™ branded yeast extract platform in late 2024, expanding savory flavor and umami ingredient offerings for clean-label food products, while raising EUR 500 million through a green bond issuance in early 2025 to fund sustainability initiatives amid expanding biobased production capacities in Asia.
DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript
DSM-Firmenich AG (KDSKF) Q4 2025 Earnings Call Transcript
DSM-Firmenich AG (DSFIY) Shareholder/Analyst Call Transcript
DSM-Firmenich AG (KDSKF) Q3 2025 Sales Call Transcript
Artisan International Value Fund Q3 2025 Portfolio Update
DSM-Firmenich AG (DSFIY) Q2 2025 Earnings Call Transcript
DSM-Firmenich AG (KDSKF) Q1 2025 Earnings Call Transcript
DSM-Firmenich AG (KDSKF) Q3 2024 Earnings Call Transcript
DSM-Firmenich AG (KDSKF) Q2 2024 Earnings Call Transcript